BioSpace News Archive

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has initiated the pivotal efficacy study for tirnovetmab (KIND-016), a fully caninized, high-affinity monoclonal antibody targeting interleukin (IL)-31 for the treatment of atopic dermatitis in dogs.

Skyhawk Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today a strategic research collaboration and licensing agreement aimed at the discovery and development of novel small molecules that modulate RNA splicing for the treatment of serious diseases.

Neogen Corporation announced that revenues for the second quarter of its 2021 fiscal year, which ended Nov. 30, were $115,000,000, a 7% increase compared to the previous year’s second quarter revenues of $107,803,000.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) , a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, announces that Michael Poirier , Chairman, Chief Executive Officer and President, has issued a letter to Qualigen’s stockholders. The full text is as follows: To

Infor today announced a global strategic partnership with MphRx to help healthcare organizations drive vaccine management for the novel Coronavirus. Even though the United States has advanced to the vaccination phase

John Howell , Co-Founder and President of the ComSovereign Holding Corporation (Symbol: COMS), the U.S.-based provider of 4G LTE Advanced and 5G-NR (New Radio Systems) communications and technology systems, has been named to the Board of Directors for the Muscular Dystrophy Association (MDA).

Beyeonics Surgical is a medical technology company developing surgeon-centered visualization solutions. Operating from Israel, the company leverages cutting-edge imaging and head-mounted display (HMD) technologies originally developed for aerospace applications. Dr. Bakalash became Chief medical officer of Beyeonics Surgical on

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on today’s passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill). Immunosuppressive medication compliance is a critical co

Oncora Medical, an oncology data and software company, has been selected to power the Pediatric Proton/Photon Consortium Registry (PPCR), run out of the Mass General Cancer Center (MGCC), with their Oncora Analytics software platform. The PPCR is a consented registry for pediatric cancer patients with the

The first prospective, case-controlled clinical study of an Engineered Sharps Injury Prevention (ESIP) device to prevent Needle Stick Injuries (NSI) in an operating room demonstrated that the use of Operative Armour ® , a wearable needle safety and workflow efficiency device, reduces surgical needle passes and handling during surgi